LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A Operating Income

As of the most recent data (June 2026), LFMDP shows a operating income of $-17M. That compares with $5.5M in the prior-year period — down 403.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, LFMDP's operating income is now $-17M (was $5.5M) — a 403.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A is outperforming or lagging.

Tracking LFMDP's operating income over time shows whether LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A is scaling, shrinking, or reshaping that part of the business. The current reading is $-17M That compares with $5.5M in the prior-year period — down 403.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this operating income page, Stockcircle has LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $-17M) with ownership activity and broader fundamentals.

LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A's operating income is $-17M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.